STOCK TITAN

Sight Sciences (SGHT) COO sells shares to cover RSU tax, retains 664,709 stake

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Sight Sciences, Inc. Chief Operating Officer Alison Bauerlein reported an open-market sale of 24,184 shares of common stock at a weighted average price of $5.36 per share. According to the disclosure, the sale was made to cover her tax liability arising from the vesting of restricted stock units. After this transaction, she holds a total of 664,709 shares, including 192,669 shares of common stock and 472,040 shares subject to unvested restricted stock units that may be acquired upon future vesting and settlement.

Positive

  • None.

Negative

  • None.

Insights

COO’s sale is mainly tax-related and small versus total equity stake.

The transaction shows COO Alison Bauerlein sold 24,184 shares of Sight Sciences at a weighted average of $5.36 per share. The company states the sale was made to cover tax liabilities from recently vested restricted stock units, which is a common administrative event.

After the sale she still holds 664,709 shares, combining 192,669 common shares and 472,040 shares tied to unvested RSUs. This indicates the sale is a small fraction of her overall equity exposure. The filing also notes the shares were sold in multiple trades between $5.19 and $5.46 per share, but does not reference any trading plan.

Insider Bauerlein Alison
Role Chief Operating Officer
Sold 24,184 shs ($130K)
Type Security Shares Price Value
Sale Common Stock 24,184 $5.36 $130K
Holdings After Transaction: Common Stock — 664,709 shares (Direct, null)
Footnotes (1)
  1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 192,669 shares of Common Stock, and (ii) 472,040 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.
Shares sold 24,184 shares Open-market sale on 2026-07-02 to cover tax liability
Weighted average sale price $5.36 per share Common stock sale on 2026-07-02
Post-transaction holdings 664,709 shares Total shares after reported sale
Common shares held 192,669 shares Portion of total post-transaction holdings
Unvested RSU-linked shares 472,040 shares Shares to be acquired upon RSU vesting and settlement
Sale price range $5.19–$5.46 per share Range of individual trade prices in the sale
Net shares sold 24,184 shares Net change in position from this Form 4
restricted stock units ("RSUs") financial
"in connection with the vesting of restricted stock units ("RSUs")."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
weighted average price financial
"Reflects the weighted average price at which the shares of Common Stock were sold."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
tax liability financial
"sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units"
vesting and settlement financial
"shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested."
Common Stock financial
"shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Sight Sciences (SGHT) COO Alison Bauerlein report in this Form 4?

She reported selling 24,184 shares of Sight Sciences common stock at a weighted average price of $5.36 per share. The company explains the sale was made to cover her tax liability from the vesting of restricted stock units.

Why did the Sight Sciences (SGHT) COO sell 24,184 shares of stock?

The sale was undertaken to cover the reporting person’s tax liability related to the vesting of restricted stock units. Such tax-driven sales are common when equity awards vest and create income, rather than indicating a discretionary reduction in overall ownership.

How many Sight Sciences (SGHT) shares does the COO hold after this transaction?

Following the sale, Alison Bauerlein holds 664,709 shares linked to Sight Sciences. This total includes 192,669 shares of common stock and 472,040 shares that will be acquired upon the vesting and settlement of currently unvested restricted stock units.

At what prices were the Sight Sciences (SGHT) shares sold in this Form 4?

The weighted average sale price was $5.36 per share, with individual trades executed between $5.19 and $5.46. The filer notes that detailed information on the number of shares sold at each specific price is available upon request.

Is the Sight Sciences (SGHT) COO’s stock sale a large part of her holdings?

The sale involves 24,184 shares, while post-transaction holdings total 664,709 shares. This indicates the transaction represents a relatively small portion of her overall equity position when considering both common shares and unvested restricted stock units.

What role do restricted stock units (RSUs) play in the Sight Sciences (SGHT) COO’s ownership?

Unvested RSUs are a major component of her stake, with 472,040 shares deliverable upon vesting and settlement. These RSUs reflect ongoing equity-based compensation and help align the executive’s long-term interests with those of other shareholders.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bauerlein Alison

(Last)(First)(Middle)
C/O SIGHT SCIENCES, INC.
4040 CAMPBELL AVE., SUITE 100

(Street)
MENLO PARK CALIFORNIA 94025

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/02/2026S24,184(1)D$5.36(2)664,709(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. Includes (i) 192,669 shares of Common Stock, and (ii) 472,040 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.
/s/Jeremy Hayden, Attorney-in-Fact for Alison Bauerlein07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)